Ohba, S., & Hirose, Y. (2017). DRES-03. INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE. Neuro Oncol.
Citação norma ChicagoOhba, Shigeo, and Yuichi Hirose. "DRES-03. INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE." Neuro Oncol 2017.
Citação norma MLAOhba, Shigeo, and Yuichi Hirose. "DRES-03. INHIBITION OF HOMOLOGOUS RECOMBINATION RESENSITIZES TEMOZOLOMIDE-RESISTANT GLIOMA CELLS TO TEMOZOLOMIDE." Neuro Oncol 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.